Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Genprex, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +3 vs. Q4 2024
- Shares held
- 384.6K
- +93.0K (+31.9%) vs. Q4 2024
- Total value
- $93.5K
- −$153.4K (−62.1%) vs. Q4 2024
- New holders
- 4
- 8 more added
- Sold out
- 1
- 4 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 63 | $0 | 0.00% | −5,000−98.8% | Reduced |
| JPMorgan Chase & Co | 5 | $1 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 114 | $28 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 125 | $34 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 148 | $35 | 0.00% | −254−63.2% | Reduced |
| Nemes Rush Group LLC | 250 | $61 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 493 | $121 | 0.00% | +4+0.8% | Added |
| HighMark Wealth Management LLC | 500 | $123 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 512 | $126 | 0.00% | +512 | New |
| Morgan Stanley | 958 | $235 | 0.00% | −8,415−89.8% | Reduced |
| SBI Securities Co., Ltd. | 2,441 | $599 | 0.00% | +1,950+397.1% | Added |
| IFP Advisors, Inc | 4,484 | $1.10K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,001 | $1.39K | 0.00% | +11+0.2% | Added |
| BlackRock, Inc. | 9,485 | $2.33K | 0.00% | 00.0% | Unchanged |
| Corsair Capital Management, L.P. | 10,000 | $2.45K | 0.00% | +10,000 | New |
| TCG Advisory Services, LLC | 13,500 | $3.31K | 0.00% | +13,500 | New |
| Vanguard Group Inc | 15,315 | $3.75K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 25,424 | $6.00K | 0.00% | −55,000−68.4% | Reduced |
| Two Sigma Securities, LLC | 42,174 | $10.3K | 0.00% | +23,184+122.1% | Added |
| UBS Group AG | 42,686 | $10.5K | 0.00% | +36,000+538.4% | Added |
| HRT Financial LP | 46,720 | $11.0K | 0.00% | +29,644+173.6% | Added |
| HighTower Advisors, LLC | 79,500 | $19.5K | 0.00% | +65,673+475.0% | Added |
| Geode Capital Management, LLC | 83,695 | $20.5K | 0.00% | +7,650+10.1% | Added |
| Curio Wealth, LLC | 1 | – | – | +1 | New |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −26,431−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |